Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria (Q37578137)
Jump to navigation
Jump to search
scientific article published in August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria |
scientific article published in August 2009 |
Statements
1 reference
Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria (English)
1 reference
Walter P Maksymowych
1 reference
Robert Landewé
1 reference
Dafna D Gladman
1 reference
Daniel Aletaha
1 reference
Robert D Inman
1 reference
Tore K Kvien
1 reference
William J Taylor
1 reference
Désirée van der Heijde
1 reference
George A Wells
1 reference
Philip J Mease
1 reference
Christopher J Ritchlin
1 reference
Oliver Fitzgerald
1 reference
Silje W Syversen
1 reference
Joan M Bathon
1 reference
Patrick Garnero
1 reference
Piet Geusens
1 reference
Hani El-Gabalawy
1 reference
Virginia B Kraus
1 reference
Mikkel Ostergaard
1 reference
Vivien P Bykerk
1 reference
Paul-Peter Tak
1 reference
Maarten Boers
1 reference
1 August 2009
1 reference
1 reference
36
1 reference
8
1 reference
1785-1791
1 reference
Identifiers
1 reference
1 reference